Members of our leadership team will be attending the CIRSE 2025 Annual Congress, organized by the Cardiovascular and Interventional Radiological Society of Europe, taking place in Barcelona, Spain, from September 13–17.

Be sure to visit Robert Arch, PhD, SVP Corporate Development and Theresa Visarius, PhD, VP of Business Development at Booth #54 for an opportunity to learn more about how Immunophotonics continues to explore the ability of IP-001 to transform a routine interventional-oncology procedure into a systemic immunotherapy against cancer.